Navigation Links
New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
Date:8/19/2007

Findings Represent Strongest Support for Coiling Since Groundbreaking 2002

Trial

DANA POINT, Calif., Aug. 1 /PRNewswire/ -- A new study reveals that coiling, a minimally invasive procedure to treat aneurysms in the brain, is successful in preventing recurrent or first-time bleeding years after initial treatment in those aneurysms considered "untouchable" by the traditional surgical option. One of the most significant findings since the 2002 release of the International Subarachnoid Aneurysm Trial or ISAT (the trial that established coiling as a safe and effective treatment), this new study's scientific value is reflected in its large patient population and length of post-procedural follow-up -- two factors that have not existed together in other post-ISAT studies to date. Results were unveiled yesterday at the fourth Annual Meeting of the American Society of Interventional & Therapeutic Neuroradiology (ASITN) in Dana Point, California.

"This study represents a unique contribution to the scientific evidence that proves coiling to be a viable treatment option," said study presenter Jo Peluso, a neurointerventional radiologist who collected and analyzed the data on behalf of colleagues W.J.J. van Rooij and M. Sluzewski, who have been performing neurointerventional procedures since the early 1990s at Saint Elisabeth Hospital in Tilburg, the Netherlands. "The clinical credibility of any procedure relies not only on the initial trials that may sanction its use on patients, but also - and perhaps equally as important - on those long-term follow-up studies that prove the procedure's success over time. This study achieves one such milestone."

A retrospective analysis, the study includes 154 consecutive patients who underwent coiling over an 11-year period (January 1995 - August 2006) on aneurysms on the tip of the basilar artery, located in front of the brain stem. Comprising approximately 8.4 percent of all brain a
'/>"/>

SOURCE American Society of Interventional & Therapeutic
Neuroradiology

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... ( http://www.researchandmarkets.com/research/vzhr6h/video ) has announced the addition of ... Growth, Trends and Forecast 2014 - 2020" report to ... of fascination since the era of the cold war between ... Russia. Earlier even a small glimpse of human form was ...
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. ... Biotechnology, Inc. for the compounding, packaging and distributing of its ... the United States . ... of compounding naltrexone tablets in various strengths for individual patients ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... 2012  The use of an injectable, clot-preventing drug known ... advanced cancer complicated by blood clots increased steadily between ... in The Oncologist , funded by the National ... despite previous research indicating LMWH is the preferred first-line ...
... 2012  MolecularHealth, Inc., a leader in clinico-molecular informatics™, ... collaboration agreement with the U.S. Food and Drug ... Molecular Analysis of Side Effects (MASE), a ... assessment and prediction. The FDA,s Center ...
Cached Medicine Technology:Injectable Treatment for Blood Clots in Advanced Cancer Patients Increases, According to New Research 2Injectable Treatment for Blood Clots in Advanced Cancer Patients Increases, According to New Research 3MolecularHealth and FDA to Collaborate on Analytical Tools for Mechanism-Based Drug Safety Assessment 2
(Date:1/22/2015)... January 22, 2015 Padre Murphy's and Owner ... of Pro Player Health Alliance (PPHA). The PPHA's ... in getting everyone, including NFL greats, treated for obstructive sleep ... leading groups supporting the cause in the valley. The most ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many ... it on Facebook, Twitter, and Pinterest. The fans will have ... a lottery every week. , Moreover, the company has extended ... Angelweddingdress homepage for more information. , Angelweddingdress ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 ... after Fresenius Medical Care recalled its GranuFlo and NaturaLyte ... multidistrict litigation underway in U.S. District Court, District of ... dated January 20th, the Court has remanded a case ...
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... PITTSBURGHIn response to the humanitarian crisis in Haiti, scientists ... publicly released spoken and textual data they,ve compiled on ... doctors, nurses and other relief workers on the earthquake-ravaged ... to make the data publicly available last week, a ...
... ... should win. , ... (Vocus) Jan. 27, 2010 -- U.S. HealthWorks Medical Group, a leading nationwide operator of on-the-job-injury ... to offer an added employee benefit by getting workers vaccinated against H1N1., , , , ...
... younger mice, researchers found , WEDNESDAY, Jan. 27 (HealthDay News) ... cells in the blood act like young stem cells, a ... process. , Taking certain factors from the blood of young ... cells take on the characteristics of younger stem cells. In ...
... cell therapy, but much research remains to be done ... Stanford University have succeeded in creating brain nerve cells ... of adult mice. , The new approach could revolutionize ... cells choose and maintain their specialized roles in the ...
... Syncare, LLC ... ... LLC ( www.syncarellc.com ) announced today that it has completed the sale of all assets ... ,An aggressive and well-respected consumer advocate of quality healthcare for the uninsured and under insured, ...
... USA Football’s 2010 ... ... Football, the sport’s national governing body on youth and amateur levels, announced today that the ... for USA Football’s “Team USA vs. The World” game, presented by Riddell, in ...
Cached Medicine News:Health News:Carnegie Mellon releases data on Haitian Creole to hasten development of translation tools 2Health News:Twitter Contest: Free, Onsite H1N1 Vaccination Day for Winning Businesses 2Health News:Aging of Blood Stem Cells May Be Reversible 2Health News:Scientists Turn Mouse Skin Cells Into Nerve Cells 2Health News:Scientists Turn Mouse Skin Cells Into Nerve Cells 3Health News:SynCare, LLC Completes Sale of Assets to Stephanie DeKemper 2Health News:SynCare, LLC Completes Sale of Assets to Stephanie DeKemper 3Health News:The Andrews Institute and Reebok Join Partner Roster for USA Football's “Team USA vs. The World” Game, Presented By Riddell 2Health News:The Andrews Institute and Reebok Join Partner Roster for USA Football's “Team USA vs. The World” Game, Presented By Riddell 3
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
DMSO-resistant microplate sealing film...
Sealing tape, white Rayon, breathable, NS...
Sealing tape, slightly stiffer than Polyolefin tape. Certified RNase and DNase free....
Medicine Products: